1. Home
  2. VYGR vs BVFL Comparison

VYGR vs BVFL Comparison

Compare VYGR & BVFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

N/A

Current Price

$1.62

Market Cap

193.5M

Sector

Health Care

ML Signal

N/A

BVFL

BV Financial Inc.

N/A

Current Price

$20.93

Market Cap

178.8M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
VYGR
BVFL
Founded
2013
1873
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Savings Institutions
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
193.5M
178.8M
IPO Year
2015
2023

Fundamental Metrics

Financial Performance
Metric
VYGR
BVFL
Price
$1.62
$20.93
Analyst Decision
Strong Buy
Analyst Count
11
0
Target Price
★ $14.22
N/A
AVG Volume (30 Days)
★ 945.7K
9.7K
Earning Date
11-05-2026
10-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.19
EPS
N/A
★ 0.97
Revenue
★ $10,135,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$172.11
N/A
P/E Ratio
★ N/A
$21.84
Revenue Growth
N/A
N/A
52 Week Low
$1.48
$17.16
52 Week High
$5.19
$22.70

Technical Indicators

Market Signals
Indicator
VYGR
BVFL
Relative Strength Index (RSI) 36.85 41.47
Support Level N/A $20.36
Resistance Level $2.04 $21.86
Average True Range (ATR) 0.15 0.42
MACD 0.01 -0.09
Stochastic Oscillator 16.22 11.85

Price Performance

Historical Comparison
VYGR
BVFL

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a biotechnology company to leverage the power of human genetics to modify the course of and ultimately cure neurological diseases. Its pipeline includes programs for Alzheimer's disease, or AD; Friedreich's ataxia, or FA; Parkinson's disease, or PD; and multiple other diseases of the central nervous system, or CNS. Many of its programs are derived from its TRACER (Tropism Redirection of AAV by Cell-type-specific Expression of RNA) adeno-associated virus, or AAV, capsid discovery platform, which the company has used to generate novel capsids, or TRACER Capsids, and identify associated receptors to potentially enable high brain penetration with genetic medicines following intravenous, or IV, dosing. Its segment is developing and commercializing genetic medicine.

About BVFL BV Financial Inc.

BV Financial Inc is a federally-chartered savings and loan holding company engaged in offering traditional financial services to consumers and businesses. The company offers savings, interest checking, money market, personal and business checking, non-interest checking, education savings, small business checking, and business checking and certificates of deposit and IRA certificates of deposit. It operates in one segment commercial banking. The company's sources of revenue are derived from interest and dividends earned on loans and investment securities.

Share on Social Networks: